FR2645173B1 - Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v - Google Patents

Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v

Info

Publication number
FR2645173B1
FR2645173B1 FR898904052A FR8904052A FR2645173B1 FR 2645173 B1 FR2645173 B1 FR 2645173B1 FR 898904052 A FR898904052 A FR 898904052A FR 8904052 A FR8904052 A FR 8904052A FR 2645173 B1 FR2645173 B1 FR 2645173B1
Authority
FR
France
Prior art keywords
peptides
cloning
fragments
expression
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR898904052A
Other languages
English (en)
Other versions
FR2645173A1 (fr
Inventor
Noel Tordle Virus Mokola
Diagnostic Des Lyssavirus O Au
Herve Bourhy
Roger Ollo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR898904052A priority Critical patent/FR2645173B1/fr
Priority to PCT/FR1990/000216 priority patent/WO1990011358A1/fr
Priority to EP90907112A priority patent/EP0465602A1/fr
Priority to JP2506608A priority patent/JPH04506747A/ja
Publication of FR2645173A1 publication Critical patent/FR2645173A1/fr
Priority to OA60078A priority patent/OA09556A/fr
Application granted granted Critical
Publication of FR2645173B1 publication Critical patent/FR2645173B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR898904052A 1989-03-29 1989-03-29 Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v Expired - Fee Related FR2645173B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR898904052A FR2645173B1 (fr) 1989-03-29 1989-03-29 Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v
PCT/FR1990/000216 WO1990011358A1 (fr) 1989-03-29 1990-03-29 Procede de detection et/ou d'identification des infections a lyssavirus, clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du lyssavirus mokola, vaccin contre le virus mokola et/ou l'ensemble des lyssavirus ainsi que procede d'obtention dudit vaccin par genie genetique
EP90907112A EP0465602A1 (fr) 1989-03-29 1990-03-29 PROCEDE DE DETECTION ET/OU D'IDENTIFICATION DES INFECTIONS A $i(LYSSAVIRUS), CLONAGE ET EXPRESSION DE GENES CODANT POUR DES PEPTIDES ET/OU DES FRAGMENTS DE PEPTIDES DU $i(LYSSAVIRUS) MOKOLA, VACCIN CONTRE LE VIRUS MOKOLA ET/OU L'ENSEMBLE DES $i(LYSSAVIRUS) AINSI QUE PROCEDE D'OBTENTION DUDIT VACCIN
JP2506608A JPH04506747A (ja) 1989-03-29 1990-03-29 リサウィルス感染症の検出法および／または同定法、モコラリサウィルスのペプチドおよび／またはペプチドの断片をコードする遺伝子のクローン化と発現、モコラウィルスおよび／またはリサウィルス群に対するワクチン、および遺伝子工学による前記ワクチンの製造方法
OA60078A OA09556A (fr) 1989-03-29 1991-09-27 Procede de detection et/ou d'identification des infections a Lyssavirus clonage et expression de genes codant pour de peptides et/ou des fragments de peptides du Lyssavirus Mokola vaccin contre le virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898904052A FR2645173B1 (fr) 1989-03-29 1989-03-29 Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v

Publications (2)

Publication Number Publication Date
FR2645173A1 FR2645173A1 (fr) 1990-10-05
FR2645173B1 true FR2645173B1 (fr) 1994-06-17

Family

ID=9380140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898904052A Expired - Fee Related FR2645173B1 (fr) 1989-03-29 1989-03-29 Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v

Country Status (5)

Country Link
EP (1) EP0465602A1 (fr)
JP (1) JPH04506747A (fr)
FR (1) FR2645173B1 (fr)
OA (1) OA09556A (fr)
WO (1) WO1990011358A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020820A1 (fr) * 1991-05-15 1992-11-26 Vanderbilt University Methode de determination du potentiel metastatique des cellules tumorales
CN113185608B (zh) * 2021-05-08 2022-08-09 南昌大学 一种高亲和力抗狂犬病病毒的全人源单克隆抗体及其用途
CN114989296B (zh) * 2022-06-21 2023-08-11 龙湖现代免疫实验室 一种狂犬病毒的单克隆抗体2f2及通用型狂犬病毒抗体快速检测试纸

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
EP0228036A3 (fr) * 1985-12-18 1988-09-07 Microgenesys, Inc. Méthode de production de polypeptides sélectionnés dans des cellules d'insectes infectées par des virus et polypeptides ainsi isolés
EP0237686A1 (fr) * 1986-03-18 1987-09-23 Institut Pasteur Séquences d'ADN dérivées du génome du virus de la rage
CA1337115C (fr) * 1987-07-30 1995-09-26 Bernhard Dietzschold Vaccin contre les maladies apparentees a la rage

Also Published As

Publication number Publication date
EP0465602A1 (fr) 1992-01-15
OA09556A (fr) 1993-01-31
JPH04506747A (ja) 1992-11-26
FR2645173A1 (fr) 1990-10-05
WO1990011358A1 (fr) 1990-10-04

Similar Documents

Publication Publication Date Title
CA2127541A1 (fr) Virus recombinant de la variole porcine
IT9048315A0 (it) Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi.
BR9006252A (pt) Microemulsoes concentradas,processo de preparacao destas microemulsoes e sua utilizacao
EP0209543A4 (fr) Fragments de peptides d'apolipoproteines humaines, anticorps specifiques du type et procedes d'utilisation.
IT1270891B (it) Pigementi di ossido di ferro trasparenti, processo per la loro preparazione nonche'_loro impiego.
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
FR2645173B1 (fr) Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v
DE19681439T1 (de) Modifizierung von Polypeptidarzneimitteln zur Erhöhung des Elektrotransportflusses
EP0110791A3 (en) Peptides containing an immunogenic site of the poliovirus, and dna's containing nucleotide fragments encoding for these peptides
DE3888896T2 (de) Wärmebeständiger aufbau des halses eines kunststoffbehälters.
EP0156278A3 (en) Process for the preparation of symmetrical benzophenones substituted by fluor-containing groups, their use and symmetrical benzophenones substituted by fluor-containing groups
IT1235166B (it) Peptidi contenenti silicio, loro preparazione e loro impiego come medicamenti
DE68922888D1 (de) Verwendung eines kationischen Oberflächenaktivmittels zur Extraktion des Hauptprotein-Antigens der äusseren Membran von Chlamydia.
EP0426455A3 (en) Cloning vector plasmid, vector-primer derived therefrom and preparation method of cdna bank using the same
AP9300556A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
FR2610521B1 (fr) Nouvelles compositions cosmetiques presentant une substantivite et/ou une adherence ameliorees
DE69611546T2 (de) Herstellung von 2,6-dimethylnaphthalin
FR2671721B1 (fr) Produit pour la repigmentation naturelle des poils et des cheveux et l'amelioration de la calvitie.
GB2229484B (en) Improvements relating to builder's square
GB9402525D0 (en) Peptide fragments of hiv
AU2913189A (en) Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
FR2636234B1 (fr) Composition, procede de preparation et utilisation d'une lotion capillaire regeneratrice
GB9000287D0 (en) Peptide fragments of hiv
DD287609A7 (de) Ankerkettenstopper "progress"
FI991120A0 (fi) Vesiliukoisten peptidien pitkäaikaisesti vapautuvat koostumukset

Legal Events

Date Code Title Description
ST Notification of lapse